CR20170140A - HETEROCYCLIC SULFONAMIDE COMPOUNDS REPLACED USEFUL AS MODULATORS OF THE TRANSITORY POTENTIAL RECEIVER CHANNEL A1 (TRPA1) - Google Patents

HETEROCYCLIC SULFONAMIDE COMPOUNDS REPLACED USEFUL AS MODULATORS OF THE TRANSITORY POTENTIAL RECEIVER CHANNEL A1 (TRPA1)

Info

Publication number
CR20170140A
CR20170140A CR20170140A CR20170140A CR20170140A CR 20170140 A CR20170140 A CR 20170140A CR 20170140 A CR20170140 A CR 20170140A CR 20170140 A CR20170140 A CR 20170140A CR 20170140 A CR20170140 A CR 20170140A
Authority
CR
Costa Rica
Prior art keywords
trpa1
useful
modulators
transitory
receiver channel
Prior art date
Application number
CR20170140A
Other languages
Spanish (es)
Inventor
Po-Wai Yuen
Anthony; Estrada
Baihua Hu
Daniel; Shore
Aleksandr Kolesnikov
Lan Wang
Joseph P Lyssikatos
Guosheng Wu
Vishal Verma
Steven Do
Huifen; Chen
Yanyan Chu
Xingyu Lin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from PCT/EP2014/071593 external-priority patent/WO2015052264A1/en
Publication of CR20170140A publication Critical patent/CR20170140A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención está relacionada con los compuestos de la fórmula I o II y las sales de los mismos. Además, la presente invención se refiere a métodos de fabricación y métodos de uso de los compuestos de la fórmula I o II así como a las composiciones farmacúeticas que contienen tales compuestos. Los compuestos pueden ser útiles en el tratamiento de enfermedades y condiciones mediadas por TRPA1, tales como el dolor.The invention is related to the compounds of the formula I or II and the salts thereof. In addition, the present invention relates to manufacturing methods and methods of use of the compounds of the formula I or II as well as to the pharmaceutical compositions containing such compounds. The compounds may be useful in the treatment of diseases and conditions mediated by TRPA1, such as pain.

CR20170140A 2014-09-12 2014-10-09 HETEROCYCLIC SULFONAMIDE COMPOUNDS REPLACED USEFUL AS MODULATORS OF THE TRANSITORY POTENTIAL RECEIVER CHANNEL A1 (TRPA1) CR20170140A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2014086380 2014-09-12
PCT/EP2014/071593 WO2015052264A1 (en) 2013-10-11 2014-10-09 Substituted heterocyclic sulfonamide compounds useful as trpa1 modulators

Publications (1)

Publication Number Publication Date
CR20170140A true CR20170140A (en) 2017-10-23

Family

ID=60244236

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20170140A CR20170140A (en) 2014-09-12 2014-10-09 HETEROCYCLIC SULFONAMIDE COMPOUNDS REPLACED USEFUL AS MODULATORS OF THE TRANSITORY POTENTIAL RECEIVER CHANNEL A1 (TRPA1)

Country Status (1)

Country Link
CR (1) CR20170140A (en)

Similar Documents

Publication Publication Date Title
CL2018001685A1 (en) Heterocyclic compounds as immuno modulators.
CL2018001624A1 (en) Polycyclic antagonists of tlr7 / 8 and their use in the treatment of immune disorders
CL2018003701A1 (en) Heterocyclic compounds as immunomodulators.
CL2016002348A1 (en) Muscarinic receptor agonists
CL2018000292A1 (en) Pharmaceutical compounds
DOP2016000295A (en) COMPOUNDS AND COMPOSITIONS AS AGENTS OF THE TOLL TYPE 7 RECEIVER
ECSP16005566A (en) SULFONAMIDES AS SODIUM CHANNEL MODULATORS
BR112018005497A2 (en) heterocyclic compounds and their uses
UY36126A (en) ? 6,8-DIOXABICICLO COMPOUNDS [3.2.1] OCTANO-2,3-DIOL REPLACED AS ADDRESS AGENTS TO ASGPR ?.
CU20170162A7 (en) DERIVATIVES OF PHENYL-TIENO (2,3-D) PIRIMIDINA-HIDROXIÁCID USEFUL IN THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES, METHOD OF PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY35675A (en) SUBSTITUTED DERIVATIVES OF QUINAZOLIN-4-ONA
UY35409A (en) 2-SUBSTITUTED SUBSTITUTES AND THEIR USE AS MODULATORS OF THE OREXINE RECEIVER
GT201200201A (en) POSITIVE ALOSTERIC MODULATORS OF M1 QUINOLINE RECEPTORS
MX2017003254A (en) Substituted 2-azabicycles and their use as orexin receptor modulators.
UY37466A (en) N-HYDROXIAMIDINHETEROCICLES SUBSTITUTED AS MODULATORS OF INDOLAMINE 2,3-DIOXYGENASE
SV2017005381A (en) IMIDAZOPIRIDAZINE COMPOUNDS
CO2017011958A2 (en) Substituted benzamides and methods to use them
CL2019003275A1 (en) Pyrimidine derivatives as modulators of the pge2 receptor.
SV2016005294A (en) 2-AMINO-6-METHYL-4,4A, 5,6-TETRAHYDROPIRANE (3,4-D) (1,3) TIAZIN-8A (8H) -IL-1,3-TIAZOL-4-ILAMIDAS
EA201790570A1 (en) P2X7 MODULATORS
PE20151669A1 (en) AZETIDINYLOXPHENYLPYRROLIDINE COMPOUNDS
CL2017002498A1 (en) Pyridopyrimidinones and their use as modulators of the nmda receptor
EA201791396A1 (en) DERIVATIVES OF IMIDAZOPIRIDAZIN AS PI3Kβ INHIBITORS
PE20160596A1 (en) FORMULATION OF ATAZANAVIR AND COBICISTAT FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUSES
EA201600002A1 (en) DERIVATIVES OF SUBSTITUTED TRIAZOLOPIRIDINES